Patent · US Active

Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug

US11911388B2 · kind B2 · utility

0Cited by

166References

11Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Eva Ulrike GRAEFE-MODY · Ingelheim am Rhein, DE
Thomas KLEIN · Radolfzell, DE
Michael Mark · Biberach an der Riß, DE
Hans-Juergen WOERLE · Munich, DE

Key dates

Filing date	Feb 11, 2021
Grant date	Feb 27, 2024
Priority date	—
Expiry date	Aug 7, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P3/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the finding that certain DPP-4 inhibitors are particularly suitable for treating and/or preventing metabolic diseases, particularly diabetes, in patients with insufficient glycemic control despite a therapy with an oral and/or a non-oral antidiabetic drug.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.